[Immune thrombocytopenia].
D000086:Acetazolamide / Q000009:adverse effects; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications; D001323:Autoantibodies; D001327:Autoimmune Diseases; D001780:Blood Coagulation Tests; D002740:Chlorothiazide / Q000009:adverse effects; D003168:Complement Fixation Tests; D004342:Drug Hypersensitivity; D005455:Fluorescent Antibody Technique; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007518:Isoantibodies; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D011802:Quinidine / Q000009:adverse effects; D011803:Quinine / Q000009:adverse effects; D013156:Splenectomy; D013449:Sulfonamides / Q000009:adverse effects; D013921:Thrombocytopenia / Q000139:chemically induced / Q000209:etiology / Q000276:immunology* / Q000628:therapy; D014777:Virus Diseases / Q000150:complications
D001323:Autoantibodies; D006993:Hypnotics and Sedatives; D007518:Isoantibodies; D013449:Sulfonamides; D002740:Chlorothiazide; D011803:Quinine; D011802:Quinidine; D000086:Acetazolamide; D011241:Prednisone
Immunthrombozytopenien.